¿Influye el embarazo en el curso de la infección por SARS-CoV-2?

Bibliografía:

1. Bhatia S., Imai N., Cuomo-Dannenburg G. y cols., Report 6: relative sensitivity of international surveillance WHO Collaborating Centre for Infectious Disease Modelling MRC Centre for Global Infectious Disease Analysis Abdul Latif Jameel Institute for Disease and Emergency Analytics (J-IDEA) Imperial College London, 21.02.2020. www.imperial.ac.uk/media/imperial-college/medicine/sph/ide/gida-fellowships/Imperial-College--- COVID-19--- Relative-Sensitivity-International-Cases.pdf (consulta: 4.03.2020)
2. CDC, Frequently asked questions and answers: coronavirus disease 2019 (COVID-19) and pregnancy, https://www.cdc.gov/coronavirus/2019-ncov/specific-groups/pregnancy-faq.html (última actualización 21.02.2020) (consulta: 28.02.2020)
3. CDC, Interim laboratory biosafety guidelines for handling and processing specimens associated with 2019 novel coronavirus (2019-nCoV), https://www.cdc.gov/coronavirus/2019-nCoV/lab/lab-biosafety-guidelines.html (última actualización: 2.02.2020) (consulta: 28.02.2020)
4. CDC, Interim U.S. Guidance for Risk Assessment and Public Health Management of healthcare personnel with potential exposure in a healthcare setting to patients with coronavirus disease 2019 (COVID-19), www.cdc.gov/coronavirus/2019-ncov/hcp/guidance-risk-assesment-hcp.html (última actualización: 25.02.2020) (consulta: 1.03.2020)
5. Chan J.F., Lau S.K., To K.K. y cols., Middle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like disease, Clin. Microbiol. Rev., 2015; 28: 465–522
6. Chen N., Zhou M., Dong X. y cols., Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study, Lancet, 2020; 395: P507–513
7. ECDC, Case definition and European surveillance for human infection with novel coronavirus (2019-nCoV), https://www.ecdc.europa.eu/en/case-definition-and-europeansurveillance-human-infection-novel-coronavirus-2019-ncov (última actualización: 30.01.2020) (consulta: 1.03.2020)
8. European Centre for Disease Prevention and Control, Daily risk assessment on COVID-19, 4 March 2020, https://www.ecdc.europa.eu/en/current-risk-assessment-novel-coronavirus--situation (última actualización: 4.03.2020) (consulta: 4.03.2020)
9. ECDC Technical Report, Guidance for wearing and removing personal protective equipment in healthcare settings for the care of patients with suspected or confirmed COVID-19, 28.02.2020. www.ecdc.europa.eu/en/publications-data/guidance-wearing-and-removing-personal-protective-equipment-healthcare-settings (consulta: 1.03.2020)
10. European Centre for Disease Prevention and Control, Infection prevention and control for the care of patients with 2019-nCoV in healthcare settings, ECDC, Stockholm, 2020
11. European Centre for Disease Prevention and Control, Outbreak of acute respiratory syndrome associated with a novel coronavirus, China: first local transmission in the EU/EEA - third update, ECDC, Stockholm, 2020
12. Geller C., Varbanov M., Duval R.E., Human coronaviruses: insights into environmental resistance and its influence on the development of new antiseptic strategies, Viruses, 2012; 4: 3044–3068
13. Główny Inspektorat Sanitarny, Informacja Głównego Inspektora Sanitarnego dla szpitali w związku z dynamicznie rozwijająca się sytuacją epidemiologiczną związaną z szerzeniem się nowego koronawirusa SARS-CoV-2, Warszawa, 27.02.2020
14. Główny Inspektorat Sanitarny, Zasady postępowania z osobami podejrzanymi o zakażenie nowym koronawirusem 2019-nCoV, https://gis.gov.pl/aktualnosci/zasady-postepowania-z-osobami-podejrzanymi-o-zakazenie-nowym-koronawirusem-2019-ncov/ (última actualización: 27.01.2020) (consulta: 1.03.2020)
15. Gralinski L.E., Menachery V.D., Return of the coronavirus: 2019-nCoV, Viruses, 2020; 12: E135
16. Huang C., Wang Y., Li X. y cols,. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China, Lancet, 2020; 395: P497–506
17. Ji W., Wang W., Zhao X. y cols., Homologous recombination within the spike glycoprotein of the newly identified coronavirus may boost cross-species transmission from snake to human, J. Med. Virol., 2020; 92: 433–440
18. Lu H., Drug treatment options for the 2019-new coronavirus (2019-nCoV), Biosci. Trends., 2020, Jan 28, doi: 10.5582/bst.2020.01020
19. Severe Acute Respiratory Syndrome (SARS) Epidemiology Working Group and the participants at the Global Meeting on the Epidemiology of SARS: Consensus document on the epidemiology of severe cute respiratory syndrome (SARS), 16–17.05.2003, World Health Organization. Department of Communicable Disease Surveilance and Response; WHO/CDS/CSR/GAR/2003.11
20. Wang L.F., Eaton B.T., Bats, civets and the emergence of SARS, Curr. Top. Microbiol. Immunol., 2007; 315: 325–344
21. Wojewódzka Stacja Sanitarno-Epidemiologiczna w Gdańsku, Wymagania dotyczące pobrania i transportu materiału do badań metodą RT-PCR w kierunku zakażeń układu oddechowego powodowanych przez koronawirusy (SARS; MERS; 2019nCoV – Wuhan Chiny), http://www.wsse.gda.pl/aktualnosci-i-komunikaty/aktualnosci/1037-wymagania-dotyczace-pobrania-i-transportu-materialu-do-badan-metoda-rt-pcr-w-kierunku-zakazen-ukladu-oddechowego-powodowanych-przez-koronawirusy-sars-mers-2019ncovwuhan-chiny (última actualización: 31.01.2020) (consulta: 1.03.2020)
22. World Health Organization, Coronavirus disease (COVID-19) advice for the public: when and how to use masks, www.who.int/emergencies/diseases/novel-coronavirus-2019/advice-for-public/when-and-how-to-use-masks (consulta: 1.03.2020)
23. World Health Organization, Global Surveillance for human infection with novel coronavirus (2019-nCoV), Interim guidance v3, 31.01.2020, WHO/2019-nCoV/SurveillanceGuidance/2020
24. World Health Organization, Infection prevention and control during health care whennovel coronavirus (nCoV) infection is suspected, Interim guidance, 25.01.2020, WHO/2019-nCoV/IPC/v2020.2
25. World Health Organization, Report of the WHO–China joint mission on coronavirus disease 2019 (COVID-19), 16–24.02.2020
26. Wong S.F., Chow K.M., Leung T.N. y cols., Pregnancy and perinatal outcomes of women with severe acute respiratory syndrome, Am. J. Obstet. Gynecol., 2004; 191: 292–297
27. World Organisation for Animal Health, Information received on 01/03/2020 from Dr Thomas Sit, Chief Veterinary Officer / Assistant Director (Inspection & Quarantine), Agriculture, Fisheries and Conservation Department, Hong Kong Special Administrative Region Government, Hong Kong (SAR – PRC). www.oie.int/wahis_2/public/wahid.php/Reviewreport/Review?page_refer=MapFullEventReport&reportid=33455 (consulta: 1.03.2020)
28. Wu Z., McGoogan J.M., Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention, JAMA, Feb 24, 2020, doi: 10.1001/jama.2020.2648
29. Volz E., Baguelin M., Sangeeta B. y cols., Report 5: phylogenetic analysis of SARS-CoV-2, WHO Collaborating Centre for Infectious Disease Modelling MRC Centre for Global Infectious Disease Analysis Abdul Latif Jameel Institute for Disease and Emergency Analytics (J-IDEA) Imperial College London, 15.02.2020, https://www.imperial.ac.uk/media/imperial-college/medicine/sph/ide/gida-fellowships/Imperial-College--- COVID-19--- genetic-analysis-FINAL.pdf (consulta: 1.03.2020)
30. Zhu N., Zhang D., Wang W. y cols., A novel coronavirus from patients with pneumonia in China, 2019, N. Engl. J. Med., 2020; 382: 727–733
31. Zou L., Ruan F., Huang M. y cols., SARS-CoV-2 viral load in upper respiratory specimens of infected patients, N. Engl. J. Med., 2020; doi: 10.1056/NEJMc2001737